Scienture Holdings Inc SCNX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.37
- Day Range
- $0.36–0.38
- 52-Week Range
- $0.24–2.60
- Bid/Ask
- $0.37 / $0.38
- Shares Outstanding
- 41.06M
- Market Cap
- $15.32M
- Volume/Avg
- 142,606 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 10.87
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Stock Style Box
- Small Value
- Total Number of Employees
- 9
- Website
- https://www.scienture.com
Valuation
|
Metric
|
SCNX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.24 |
Price/Sales | 10.87 |
Price/Cash Flow | — |
Price/Earnings
SCNX
Financial Strength
|
Metric
|
SCNX
|
|---|---|
Quick Ratio | 2.83 |
Current Ratio | 3.04 |
Interest Coverage | −12.19 |
Quick Ratio
SCNX
Profitability
|
Metric
|
SCNX
|
|---|---|
Return on Assets (Normalized) | −13.20% |
Return on Equity (Normalized) | −16.86% |
Return on Invested Capital (Normalized) | −12.86% |
Return on Assets
SCNX
Pharmaceutical Retailers Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| JD Health International Inc
JDHIF
| — | LOCK|&##pL | $15B | |||
| JD Health International Inc ADR
JDHIY
| — | LOCK|$Vh@c | $15B | |||
| Raia Drogasil SA ADR
RADLY
| — | LOCK|vzV# | $7B | |||
| MatsukiyoCocokara & Co
MSMKF
| — | LOCK|&?# | $7B | |||
| Alibaba Health Information Technology Ltd ADR
ALBBY
| — | LOCK|kpQd | $6B | |||
| Alibaba Health Information Technology Ltd
ALBHF
| — | LOCK|?%jr! | $6B | |||
| Sugi Holdings Co Ltd
SGIPF
| — | LOCK|h^? | $3B | |||
| Clicks Group Ltd ADR
CLCGY
| — | LOCK|b#h@> | $3B | |||
| Clicks Group Ltd
CCKRF
| — | LOCK|XRr@k | $3B | |||
| Ain Holdings Inc
AINPF
| — | LOCK|m<T | $1B |
United States